
INFINITY TENS - 8 Modes, Dual Channel, Rechargeable Pain Relief Massager,

TIGIT and PD-1 join forces to inhibit CD226 costimulation,

Addressing treatment switching in the ALTA-1L trial with g-methods: exploring the impact of model specification | BMC Medical Research Methodology | Full Text,

Phase I/Ib, open-label, multicenter, dose-escalation study of the anti-TGF-β monoclonal antibody, NIS793, in combination with spartalizumab in adult patients with advanced tumors | Journal for ImmunoTherapy of Cancer,

Frontiers | A Phase 1 Dose-Escalation Study of PF-06671008, a Bispecific T-Cell-Engaging Therapy Targeting P-Cadherin in Patients With Advanced Solid Tumors